×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Richard E. Lowenthal

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOAug 21, 2025Sale$14.4950,000724,3451,196,494Aug 22, 2025, 04:30 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEODec 17, 2024Sale$11.6750,000583,5251,098,499Dec 19, 2024, 04:20 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEODec 17, 2024Sale$11.6750,000583,5751,297,447Dec 19, 2024, 04:20 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEODec 10, 2024Sale$13.1650,000658,1551,148,499Dec 11, 2024, 06:30 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEODec 10, 2024Sale$13.1750,000658,2651,246,494Dec 11, 2024, 06:30 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEODec 06, 2024Option/RSU Exercise$8.4211,87699,9964,327,189Dec 09, 2024, 05:25 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEODec 06, 2024Option/RSU Exercise$4.6725,665119,8523,433,512Dec 09, 2024, 05:25 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEONov 19, 2024Sale$13.9550,000697,5101,347,447Nov 21, 2024, 04:30 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEONov 19, 2024Sale$13.9550,000697,4501,198,499Nov 21, 2024, 04:30 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEONov 12, 2024Sale$16.8550,000842,3171,253,375Nov 14, 2024, 04:30 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEONov 12, 2024Sale$16.8550,000842,3261,301,449Nov 14, 2024, 04:30 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOOct 15, 2024Sale$14.8850,000743,8201,298,499Oct 17, 2024, 04:30 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOOct 15, 2024Sale$14.8850,000743,7751,398,897Oct 17, 2024, 04:30 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOOct 08, 2024Sale$13.8350,000691,3851,346,494Oct 10, 2024, 04:27 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOOct 08, 2024Sale$13.8350,000691,3901,348,499Oct 10, 2024, 04:27 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOSep 17, 2024Sale$12.9350,000646,6801,398,499Sep 19, 2024, 04:26 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOSep 17, 2024Sale$12.9350,000646,5251,447,447Sep 19, 2024, 04:26 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOSep 10, 2024Sale$11.5050,000574,9101,448,499Sep 12, 2024, 04:24 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOSep 10, 2024Sale$11.5050,000574,8651,396,494Sep 12, 2024, 04:24 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOAug 20, 2024Sale$15.0250,000751,2381,512,283Aug 21, 2024, 06:47 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOAug 20, 2024Sale$15.0350,000751,3481,511,503Aug 21, 2024, 06:47 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOAug 13, 2024Sale$12.4850,000623,7871,481,895Aug 15, 2024, 04:30 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOAug 13, 2024Sale$12.4850,000623,7681,583,862Aug 15, 2024, 04:30 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOJul 16, 2024Sale$11.4050,000570,1551,598,499Jul 18, 2024, 04:30 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOJul 16, 2024Sale$11.4050,000570,1401,547,447Jul 18, 2024, 04:30 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOJul 09, 2024Sale$9.6250,000480,8401,648,499Jul 11, 2024, 05:03 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOJul 09, 2024Sale$9.6250,000480,8851,496,494Jul 11, 2024, 05:03 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOJun 12, 2024Sale$9.1547,834437,4611,546,494Jun 13, 2024, 04:30 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOJun 11, 2024Sale$9.001,97217,7561,746,527Jun 13, 2024, 04:30 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOJun 11, 2024Sale$9.002,16619,4981,594,328Jun 13, 2024, 04:30 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOJun 12, 2024Sale$9.1448,028439,2021,698,499Jun 13, 2024, 04:30 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMay 16, 2024Sale$9.0644,350401,7091,748,499May 16, 2024, 07:51 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMay 16, 2024Sale$9.0644,746405,3141,597,447May 16, 2024, 07:51 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMay 14, 2024Sale$9.012,88425,9731,795,615May 16, 2024, 07:51 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMay 14, 2024Sale$9.012,87325,8811,644,574May 16, 2024, 07:51 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMay 15, 2024Sale$9.042,76625,0051,792,849May 16, 2024, 07:51 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMay 15, 2024Sale$9.052,38121,5591,642,193May 16, 2024, 07:51 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMay 07, 2024Sale$9.3450,000467,1351,596,494May 09, 2024, 06:57 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMay 07, 2024Sale$9.3450,000467,2301,798,499May 09, 2024, 06:57 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOApr 23, 2024Option/RSU Exercise$1.06130,993138,9903,407,847Apr 24, 2024, 06:17 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOApr 19, 2024Option/RSU Exercise$1.06188,491199,9994,315,313Apr 22, 2024, 07:22 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOApr 16, 2024Sale$9.2850,000463,9851,848,499Apr 17, 2024, 06:40 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOApr 16, 2024Sale$9.2850,000464,0201,647,447Apr 17, 2024, 06:40 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOApr 09, 2024Sale$9.2850,000463,8851,646,494Apr 10, 2024, 05:36 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOApr 09, 2024Sale$9.2850,000463,8501,898,499Apr 10, 2024, 05:36 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMar 22, 2024Sale$9.011,32611,9521,996,131Mar 26, 2024, 06:48 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMar 22, 2024Sale$9.031,0179,1831,745,082Mar 26, 2024, 06:48 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMar 25, 2024Sale$9.1247,632434,5751,948,499Mar 26, 2024, 06:48 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMar 25, 2024Sale$9.1247,635434,6121,697,447Mar 26, 2024, 06:48 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMar 19, 2024Sale$9.049428,5131,997,557Mar 21, 2024, 09:51 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMar 19, 2024Sale$9.039768,8111,746,471Mar 21, 2024, 09:51 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMar 21, 2024Sale$9.001009001,997,457Mar 21, 2024, 09:51 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMar 21, 2024Sale$9.003723,3481,746,099Mar 21, 2024, 09:51 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMar 15, 2024Sale$9.1448,295441,4891,696,494Mar 15, 2024, 07:55 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMar 13, 2024Sale$9.001,30011,7002,047,199Mar 15, 2024, 07:55 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMar 13, 2024Sale$9.001,50013,5001,744,994Mar 15, 2024, 07:55 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMar 14, 2024Sale$9.002392,1512,046,960Mar 15, 2024, 07:55 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMar 14, 2024Sale$9.002051,8451,744,789Mar 15, 2024, 07:55 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOMar 15, 2024Sale$9.1448,461442,9971,998,499Mar 15, 2024, 07:55 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOFeb 29, 2024Sale$9.021,0009,0191,747,447Mar 01, 2024, 08:17 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOFeb 29, 2024Sale$9.011,98217,8672,048,499Mar 01, 2024, 08:17 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOFeb 29, 2024Sale$9.028007,2151,746,494Mar 01, 2024, 08:17 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOFeb 28, 2024Sale$9.0249,019442,2102,050,481Feb 28, 2024, 09:04 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOFeb 28, 2024Sale$9.0225,456229,6261,747,294Feb 28, 2024, 09:04 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOFeb 28, 2024Sale$9.0224,303219,2251,748,447Feb 28, 2024, 09:04 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOFeb 26, 2024Sale$9.015004,5052,099,500Feb 28, 2024, 09:04 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOFeb 26, 2024Sale$9.011009011,772,750Feb 28, 2024, 09:04 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPRESIDENT AND CEOFeb 26, 2024Sale$9.011009011,772,750Feb 28, 2024, 09:04 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPresident and CEOMay 17, 2023Gift-2,100,000-2,100,000Jan 04, 2024, 04:53 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPresident and CEOMay 17, 2023Gift-1,050,000-3,276,854Jan 04, 2024, 04:53 PM
SPRYARS Pharmaceuticals, Inc.Richard E. LowenthalPresident and CEOMay 17, 2023Gift-1,050,000-4,126,822Jan 04, 2024, 04:53 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe